London, England-- (SBWIRE) -- 11/16/2010 -- The US gum and wood chemical manufacturing industry is highly concentrated with fewer relatively similar sized companies operating in the region as stated by the new market research report on gum and wood chemicals market. Recreational cooking market accounts for about 80-90% of the charcoal briquette consumption in the US. The most significant form of recreational cooking is barbequing (on a grill stove).

The gum and wood chemical industry is part of the organic chemical industry, and is primarily focused on the hardwood/softwood distillation products, tanning materials, natural dyes, rosins, charcoal, and other products. The climatic changes witnessed in recent years have dramatically changed the flora and fauna across the world. Consequently, the forests and other natural resources are shrinking across the world; therefore forest-based industries are under pressure from rising raw material costs and hence production costs.

The US market for gum and wood chemicals is projected to reach US $1.6 billion by the year 2015. This is primarily driven by the growing population across regions, and increasing demand for charcoal in power generation, pharmaceuticals, steel manufacture, and various other industries.

The report titled Gum And Wood Chemicals: A US Market Report provides a comprehensive review of industry overview, product overview, profiles of major players, and recent industry activity. The report analyzes market data and analytics in terms of value for the US region.

Key players profiled in the report include Abbey Color, Arizona Chemical Company, Borregaard LignoTech, Braai & BBQ International, Braaistar, Ceresking Ecology & Technology Co., Ltd., Deqing Yinlong Industrial Co., Ltd., E & C Charcoal (Pty) Ltd, Forchem Oy, Georgia-Pacific Chemicals, LLC, Krone Carbon, and Resinas Sinteticas, among others.

Veiw more details no the report: The US gum and wood chemical manufacturing industry is highly concentrated with fewer relatively similar sized companies operating in the region as stated by the new market research report on gum and wood chemicals market. Recreational cooking market accounts for about 80-90% of the charcoal briquette consumption in the US. The most significant form of recreational cooking is barbequing (on a grill stove).

The gum and wood chemical industry is part of the organic chemical industry, and is primarily focused on the hardwood/softwood distillation products, tanning materials, natural dyes, rosins, charcoal, and other products. The climatic changes witnessed in recent years have dramatically changed the flora and fauna across the world. Consequently, the forests and other natural resources are shrinking across the world; therefore forest-based industries are under pressure from rising raw material costs and hence production costs.

The US market for gum and wood chemicals is projected to reach US $1.6 billion by the year 2015. This is primarily driven by the growing population across regions, and increasing demand for charcoal in power generation, pharmaceuticals, steel manufacture, and various other industries.

The report titled Gum And Wood Chemicals: A US Market Report provides a comprehensive review of industry overview, product overview, profiles of major players, and recent industry activity. The report analyzes market data and analytics in terms of value for the US region.

Key players profiled in the report include Abbey Color, Arizona Chemical Company, Borregaard LignoTech, Braai & BBQ International, Braaistar, Ceresking Ecology & Technology Co., Ltd., Deqing Yinlong Industrial Co., Ltd., E & C Charcoal (Pty) Ltd, Forchem Oy, Georgia-Pacific Chemicals, LLC, Krone Carbon, and Resinas Sinteticas, among others.

Veiw more details no the report: http://www.companiesandmarkets.com/r.ashx?id=Y2C4152LO289259&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- North America and Europe represents the largest markets worldwide for H1N1 Vaccines, as stated by the new market research report on H1N1 Vaccines. Robust sales growth experienced during initial period will substantially decrease with passing year, with great proportion of the global population getting vaccination against the pandemic virus. With pandemic situation easing in several countries demand for H1N1 vaccines is expected to gradually recede, specifically in the US, Europe, and Canada. Intramuscular vaccines or flu shots account for majority of market revenues, followed by intranasal vaccines.

The report titled H1N1 Vaccines: A Global Strategic Business Report, provides a comprehensive review on the global H1N1 pandemic situation, regional data, statistical review of confirmed and suspected cases by region, deaths by region, the H1N1 vaccines availability, the manufacturers involved, current market analysis, future prospects, vaccines availability across different regions, disease overview, regulatory approvals, recent industry activity, and focus on key market participants. The study analyzes market data and analytics in terms of value sales for regions including the United States, Europe, Asia-Pacific, and Rest of World.

The world market for H1N1 Vaccines is projected to reach $544.3 million by 2015. With the World Health Organization declaring H1N1 influenza as pandemic in 2009, H1N1 vaccines emerged as a vital tool to combat the infection and to protect thousands of people against the deadly disease. Increased awareness among people regarding the pandemic situation contributed for overwhelming growth of H1N1 vaccines during 2009. These vaccines have been so far successful in easing pandemic outbreak in several countries.

Backed by public health measures and continuing vaccination campaigns around the world, the rate of transmission of H1N1 virus, colloquially called swine flu, is slowing gradually with the pandemic situation easing in many countries. Presently, the H1N1 pandemic is referred to be "moderately" severe, since majority of individuals had been vaccinated against the virus and significant proportion of patients experiencing fast recovery.

Key players profiled in the report include Baxter International Inc., CPL Biologicals Pvt. Ltd., CSL Limited, GlaxoSmithKline Plc, MedImmune LLC., Novartis AG, Sanofi Pasteur SA, Simcere Pharmaceutical Group, Sinovac Biotech Ltd, Solvay SA, and Zydus Cadila.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=M6AIL461A289258&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- Europe and the United States dominate the world hats, caps, and millinery market as stated by the new market research report on Hats, Caps, and Millinery. Most of the marketed caps in the US are non-durable and disposable, which are often made of foam and plastic. Alternatively, good quality caps and hats, made of either cotton or wool, also account for a significant share in the US market. Caps or hats are now used in almost every form of sport. The US hat, cap, and millinery industry exports a significant amount of merchandise to more than one hundred countries.

Asia-Pacific represents the fastest growing market for hats, caps, and millinery. Factors contributing to the growth include rising demand from developing countries in the region, large customer base, and varied type of caps and hats available in the region.

The world market for Hats, Caps, and Millinery is projected to reach $6.3 billion by the year 2015. This is primarily driven by surging demand from emerging markets, novel fashion trends and product attributes. Further, increasing demand for retro styled hats and premium, high-priced caps is also contributing to the market growth.

Globally, caps, hats, and millinery manufacturers sell more than 300 million units every year. In 2009, the global economic slowdown affected the caps manufacturing industry worldwide. However, buoyed by the latest fashion trends, improving product attributes, and spiraling demand for premium, high-priced and retro styled hats, the market is poised to register healthy growth over the coming years. The global market for premium, high-priced caps is increasing significantly. The underlying factor that supports the cap sales differ from region to region. For instance, Japanese customers mostly opt for US-based products and designs for their premium quality and material. While, the European customers buy caps based on the preference of music celebrities' style and the hip hop culture.

The report titled Hats, Caps, and Millinery: A Global Strategic Business Report provides a comprehensive review of market trends, product overview, trade statistics, product launches, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including the United States, Canada, Europe, Asia-Pacific, Latin America and Rest of World.

Key players profiled in the report include Bollman Hat Company, Charles Owen & Co. Ltd., Dada Corporation, Gap Inc., Global Headwear Ltd., Grace Hats International LLC, Gucci, Hat World Inc., Imperial Headwear Inc., Kau Kee Garments & Hats Manufacturer Ltd., Mainland Headwear Holdings Limited, New Era Cap Co. Inc., Pukka Headwear Inc., Rosy Way Industrial Co. Ltd., Spyder Active Sports Inc., SSP Hats, totes"ISOTONER Corporation, and William Scully Limited.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=PP2J78R32289257&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England-- (SBWIRE) -- 11/16/2010 -- Over 2 million people across Europe, the US and Japan suffer from one of the two inflammatory bowel diseases, as stated by the new market research report on inflammatory bowel disease therapeutics market. The number is expected to grow considerably in near future, acting as a major driving force for the IBD therapeutics market. Prevalence of IBD is higher in developed countries of Europe, Americas and Japan, as compared to rest of world. The disease still lacks awareness among the population, as most people affected with the disease keep it low profile due to the nature of symptoms and social stigma. This in turn results in impassive seriousness among the population about the disease.

The world market for Inflammatory Bowel Disease (IBD) Therapeutics is projected to exceed US$4.3 billion by the year 2015. This is primarily driven by prevalence and incidence in the key markets of North America and Europe. Increasing preference for high priced biologics, as against conventional treatment options, is further driving the global market. Besides, factors such as unmet medical needs and an extensive pipeline of drugs with superior efficacy keep growth prospects optimistic.

With growing incidence and prevalence of Inflammatory Bowel Disease (IBD), especially in temperate regions of North America and Europe, the IBD therapeutics market is expected to grow in near future. The two forms of inflammatory bowel diseases, namely Ulcerative colitis and Crohn's disease, are considered as a type of autoimmune disorders. Key factors driving growth of this sector include increasing use of biologics, as against conventional treatment options. These biologic drugs are usually priced higher than the conventional drugs, which continue to drive revenues for manufacturers. Besides, factors such as unmet medical needs and an extensive pipeline of drugs with superior efficacy keep growth prospects optimistic.

The report titled Inflammatory Bowel Disease Therapeutics - A Global Strategic Business report provides a comprehensive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The report analyzes market data and analytics in terms of value sales of therapeutics by the following disease types - Crohn's Disease and Ulcerative Colitis.

Key players profiled in the report include Abbott Laboratories, GlaxoSmithKline plc, Johnson & Johnson, Merck Serono, Millennium Pharmaceuticals, Inc., Mitsubishi Tanabe Pharma Corporation, Novartis AG, Shire plc, and UCB SA, among others.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=DN3E452HB289254&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- Europe and the United States dominate the men's grooming products market worldwide, as stated by the new market research report on men's grooming products. Shaving Products, comprising of pre-shave products, post-shave products, and razors/blades represents the largest group within the men's grooming products market. Toiletries, consisting of bath and shower products, hair care products, skin care products, and deodorants, represent the fastest growing product category.

Asia-Pacific represents the fastest growing market for men's grooming products. Growing acceptance for men's grooming and prevailing life style trends in the Western world are fueling the demand for grooming products from male consumers in Asia-Pacific as well as other developing countries.

The world market for men's grooming products is projected to exceed $33.2 billion by the year 2015. This is primarily driven by a rapid rise of metrosexual male, innovative appealing products, growing middle class population, increased Internet connectivity, and universality of prestige across the world.

Men are increasingly becoming beauty conscious across the world. Male consumers are paying more attention on their looks and the trend is being driven by the male role models, including sportsmen and film personalities. As the gender boundaries are blurring, global firms are increasingly focusing on finding new ways of making profits from the emerging characteristics of men consumer segment. The trend has resulted in entry of a large number of personal care products manufacturers into the men's grooming market with cosmetics and beauty products designed exclusively for men. Niche brands helped generate interest among men for grooming products. The rise in popularity for such products led to a shift from niche to mainstream markets. The market for men's grooming products is constantly expanding with skin care and bath and shower segments leading from the front.

Men's grooming market expanded significantly from the traditional shaving products and deodorants to other categories such as skin care, hair care and bath products. Men are increasingly demanding products, which are specifically targeted at them and are selecting their own body washes and shower gels instead of borrowing from their spouse. Today, men's grooming market is significantly contributing to the growth of global cosmetics market.

The report titled Men's Grooming Products: A Global Strategic Business Report provides a comprehensive review of market trends, product overview, competition, product launches, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The global and the US markets are analyzed by the following product groups/segments - Toiletries (Bath and Shower Products, Hair Care Products, Skin Care Products, Deodorants), and Shaving Products (Pre-Shave Products, Post-Shave Products, and Razors/Blades).

The market for men's grooming products is highly competitive. Competition is particularly high in shaving products segment. Several companies are shifting focus from women's grooming products to men's grooming sector. Key players profiled in the report include Avon Products Inc., Beiersdorf AG, Colgate-Palmolive Company, Coty Inc., Lancaster Group, Energizer Holdings Inc., Johnson & Johnson, Johnson & Johnson Consumer Products Division, Limited Brands Inc., L'Oreal USA Inc., Mirato Spa, Procter & Gamble Company, The Gillette Company, Procter & Gamble Italia Spa, PZ Cussons Plc, The Estee Lauder Companies Inc., and The Unilever Group.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=Q47Q4SXP5289247&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England-- (SBWIRE) -- 11/16/2010 -- Pancreatic cancer is typically very aggressive in nature, responds rather inadequately to treatment, and is generally diagnosed when it has already reached the locally advanced or metastatic stage. The rates of mortality tend to be high, and there exists no therapy that is shown to significantly improve survival. Only a few systemic treatments are available, and just about 20% of the patients diagnosed with a resectable disease are eligible to receive the systemic therapy.

Eli Lilly's Gemzar (Gemcitabine) is the current gold standard of care for locally advanced and metastatic disease, with a dominance that is undisputed despite a median survival of less than 6 months and rate of one-year survival of around 18%, as stated by the new market research report on Pancreatic cancer drugs. Though the odds of survival are somewhat better in other forms of cancer, the rate of five-year survival for the most common form of pancreatic cancer, Adenocarcinoma of the pancreas is less than 5%, with majority of patients surviving just a few months.

A macro level perspective of the drug development projects would highlight that most clinical trials have studied combinations with Gemcitabine as a mainstay drug and none till date have been able to provide significantly superior outcomes than Gemcitabine alone. Even the combinations of biological agents and gemcitabine have not been successful. There is a kind of gemcitabine fixation, with researchers unable to think beyond the gemcitabine box, even as the disease continues to claim several thousands of lives every year.

Competition in the global pancreatic cancer drugs market is virtually non-existent where Eli Lilly's Gemzar (Gemcitabine) and Genentech/ OSI Pharmaceuticals/ Roche's Tarceva (Erlotinib) are the only therapies indicated for the treatment of pancreatic cancer. Of the two, Gemzar is the most widely prescribed therapeutic.

The report titled "Pancreatic Cancer Drugs: A Global Market Report provides a comprehensive review of the market, competitive scenario, pipeline drugs, research & development, regulatory submissions/approvals, and recent industry activity.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=06T1RTBG6289240&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- Software-as-a-Service (SaaS) in the global enterprise application software (EAS) market is projected to reach about $23.15 billion by the year 2015. Growth in the market is especially driven by the need for cost effective software delivery model, proliferation of the Internet, growth in demand for subscription-based contracts, software upgrades and replacement needs for existing applications among others.

With IT departments across all industries focusing their attention on IT cost savings in terms of capital and staffing, functionality additions at lesser costs, simplified upgrades, and savings in the form of immediate and long-term gains, customers are seen fast migrating from the conventional practice of purchasing expensive licenses for integrated enterprise application solutions to those that can be rented or hired at relatively lower costs monthly subscription fees. And SaaS in this regard is optimally positioned to offer just that, and its therefore of little surprise that Enterprise Application Software (EAS) offered as "Software as a Service" (SaaS) is witnessing strong growth worldwide. Subscription pricing models like SaaS, are expected to grow rapidly in the upcoming years, largely at the expense of license models. The need for major software upgrades, replacement of existing applications, and providing supporting functionality to existing applications, among other notable trends in the software industry is creating a substantial market for On-Demand software. Most companies, including those that invested heavily in up-front license fees, find the on-demand model cost effective, despite the sunk costs involved.

The ongoing economic slowdown has given the Software-as-a-Service market a reason to rejoice, as companies are increasingly turning to SaaS-based software delivery model to cut-down costs related to acquiring, installing, and upgrading dedicated in-house software applications. Having witnessed an encouraging growth trend in 2009, demand outlook for SaaS in the coming years also remains equally encouraging. With large international providers already making headway into this market, smaller players need to focus their attention on enhancing their capabilities. In view of low churn and high retention rates, smaller providers need to chant the innovation mantra and be versatile in providing a wide range of services. Trust factor and reliability continue to remain the key features for the success of the industry. Though the market, given the cost pressures, is more open towards SaaS model now than ever before, few areas still remain worrisome and therefore need to be addressed immediately. Awareness on the end-use benefits of SaaS is one such area of improvement and therefore it is highly important that the industry imparts proper education on advantages of using SaaS model to prospective customers.

As stated by the new market research report on Software As A Service (SaaS) in the EAS market in the US and Europe collectively account for a major share of the global market. Office Suite is the most rapidly growing EAS application market for SaaS over the analysis period 2006-2015.

The report titled Software-as-a-Service (SaaS): A Global Strategic Business Report provides a review of noteworthy market trends, growth drivers and issues. The report in addition also enumerates recent acquisitions, and other strategic industry activities. The report offers latent demand estimates and projections for SaaS in the EAS market by geographic verticals, such as, US, Japan, Europe, Asia Pacific and Rest of World, in addition to application segments, such as, Content, Communication and Collaboration (CCC), Customer Relationship Management (CRM), Enterprise Resource Planning (ERP) & Supply Chain Management (SCM), Office Suites, and Digital Content Creation (DCC), among others.

Key players in this marketplace include Ali Software (Shanghai) Co, Ltd., Citrix Online, Inc., Concur Technologies, Inc, Hewlett Packard Development Company, IntraLinks, Inc., Intuit, Inc., Kenexa Corporation, Microsoft Corporation, NetSuite, Inc., Omniture, Inc., Salesforce.com, Inc., and WebEx Communications, Inc.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=7T1120576274181&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- "India represents one of the most rapidly emerging healthcare products and services market in the world, with the worth of around US$ 45.8 Billion in 2009. Moreover, the industry has successfully been able to survive amid global financial turmoil owing to prevalence of chronic as well as communicable diseases, among which the most recent is Swine Flu.

According to our newly updated research report "Indian Healthcare - New Avenues for Growth", the potentials of the Indian healthcare industry are immense and it is expected to rise exponentially owing to increasing per capita healthcare spending and deliberate investments in this sector by the private players. It is expected that this market will grow at a CAGR of around 21% during 2010-2013. The growth of the healthcare market will mainly by driven by factors such as changing demographics profile, epidemiological transitions and increasing health insurance penetration. Our report discusses about all such key drivers that are stimulating growth in the healthcare market.

India represents the second most populated country in the world. Our research finds that with a rapidly expanding economy and increasing urbanization, prevalence of a number of chronic diseases, such as cardiovascular, diabetes, arthritis and cancer, will increase rapidly in India. In addition to this, our report also explores that sectors such as medical tourism market and pharma outsourcing market will grow at a CAGR of around 31% and 34% respectively during 2010-2013. So, the country is well-poised to become a source of opportunities for players operating in these segments.

"Indian Healthcare - New Avenues for Growth" contains unique industry research and provides a detailed and objective analysis on the Indian healthcare market. It acquaints clients with statistical and analytical overview of the Indian healthcare market coupled with past, present and future forecast till 2013 on the entire composition and functioning of the Indian healthcare sector. Forecast in this research has been done judiciously, considering the possible post-recession impacts on the industry. It also studies a number of related sectors such as hospital services, pharmaceuticals, medical devices, outsourcing services, medical tourism, infrastructure, medical textiles and path labs.

All-in-all, the research report will help clients to have proper insight of the Indian healthcare market's current and future performance. It will thus be a valuable asset for the new market entrants as it will help them in framing their strategies accordingly."

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=38Y81EL88264582&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Within the flat glass market, float glass constitutes the largest process type and accounts for a lion's share of the global flat glass demand.

London, England -- (SBWIRE) -- 11/16/2010 -- In developed markets such as Europe and the US, vehicle manufacturers are gravitating towards the use of laminated side glazings, which enhance security as well as vehicle comfort. Laminated glazings lead to larger volume of glass usage as two layers of glass are used in place of the previously used monolithic side glazings.

A major reason behind the highly consolidated market state of the float glass industry is the capital-intensive nature of the industry. Four big players, namely, Asahi Glass Co. (AGC), Nippon Sheet Glass (NSG GROUP), Saint-Gobain and Guardian Industries, dominate the global flat glass industry. Other major market participants include China Luoyang Float Glass Group Co. Ltd, CSG Holding Co. Ltd., JSC Salavatsteklo, KCC Corporation, PPG Industries, Schott Group, Sisecam Group, and Taiwan Glass.

The global market for Flat Glass is projected to exceed 34 million metric tons by 2015. The industry that was hard hit by the global economic meltdown is gradually witnessing signs of recovery, particularly led by economic growth in developing countries. Huge governmental stimulus subsequent to the economic turmoil coupled with high construction activity in the developing world is expected to fuel future growth in the global flat glass market.

Global flat glass demand turned towards negative territory in 2008 as the sub-prime crisis engulfed the entire world. The consequent full-blown recession had a deepening impact on the construction and automotive industries that account for about 80% of the flat glass demand. Capacity utilization, which had remained over 90% for the last several years, declined to below 87% in 2009. Region-wise, the decline was particularly sharp in Europe, Japan and North America. China, the single largest flat glass producer globally, also faced consequences of the meltdown. The market is currently showing signs of recovery, particularly led by economic growth in the developing countries. Huge economic stimulus provided by governments across the world is proving beneficial for the construction and automotive markets, with the positive effects percolating into the flat glass industry.

Asia-Pacific represents the largest as well as the fastest growing market for flat glass, as stated by the new market research report on Flat Glass. Rising economic affluence is expected to boost the automobile industry in these countries. In China replacement of inferior quality sheet glass by float glass and increased acceptance of fabricated glass of high value including insulating glass and safety glass are expected to shape the glass market in the next decade. Globally, factors such as increasing demand for energy conservation and implementation of new legislation for safety and noise levels at manufacturing units are fueling higher usage of glass in construction activity. Architectural market for advanced flat glass is expected to benefit from features such as low-emissivity, reflective and smart glass. In the automotive sector, increased use of value added glass, use of glazing as styling and differentiating feature, and environmental concerns are driving the use of double-glazed glass.

The industry is also deriving growth from new smart-glass products such as electrochromic, switchable glass, self-cleaning window glass and heads-up display windscreens.

The research report titled Flat Glass: A Global Strategic Business Report provides a comprehensive analysis of the global flat glass market including structural overview, market trends, drivers, product profile, end-use analysis, players and competition in the market. The report also offers profiles of leading players and presents recent developments, mergers, acquisitions, as well as other strategic industry activities. The study analyzes flat glass market by major product segments including Float Glass, Sheet Glass and Rolled Glass, and end use segments namely Construction, Automotive and Specialty. Detailed analysis is provided for major geographic markets including the US, Canada, Japan, France, Germany, the UK, Italy, Spain, Russia, Asia-Pacific, the Middle East and Latin America.

View Full Report Details: http://www.companiesandmarkets.com/Market-Report/flat-glass-a-global-strategic-business-report-400723.asp

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Europe represents the largest regional market for laminate flooring worldwide, as stated by the new market research report on Laminate Flooring.

London, England -- (SBWIRE) -- 11/16/2010 -- Ecological awareness among Europeans coupled with design, durability, and uncomplicated installation of laminate flooring drives the market in the region. European producers dominate the global market with their technical know-how and entrepreneurship. Many of these companies directed their R&D efforts towards enhancing product offerings, and to fortify their presence in overseas markets. Asia-Pacific represents the fastest growing market for laminate flooring. Technological advancements, development of glueless laminates, and improved moisture resistance are playing a major role in the market growth in the Asia-Pacific region. The laminate flooring market in Asia-Pacific is poised to grow at a compounded annual rate of more than 5.0% over the analysis period. Residential Replacement (Including DIY Inst.) constitute the largest end-use segment in the global laminate flooring market, while New Housing Starts category represents the fastest growing end-use segment.

Two unique trends in the worldwide laminate flooring market include enhancement in surface through synchronized grain and pore printing, and direct print laminate flooring through indirect gravure printing. As trends in surface designs move towards authenticity, perfection and refinement, innovations in laminate flooring take the same route. Demand is also rising due to increasing familiarity and popularity among builders and consumers. Growth can be attributed to features including enhanced performance properties such as fade and stain resistance, durability, low maintenance, lower price and improved style options. Enhancements in technologies such as embossed registration and texturing is offering consumers a cost-efficient way of attaining the looks of ceramics, tiles, and hardwood. New innovations in laminate flooring are further expected to increase the popularity of laminate flooring. The most apparent developments are in design. Realistic finishes are keeping laminate flooring one step ahead of other conventional flooring options including timber and carpet. Technological advancements, resistant surfaces, quick fixing, realistic finishes, and wide variety of designs have lent a big hand in popularizing laminate flooring. Innovative technologies such as anti-static and soundproofing were designed to address bottlenecks.

The global market for Laminate Flooring is forecast to reach 1.4 billion square meters by the year 2015. Recovery in global economic conditions, along with recovery in new residential construction represents the key factors impacting market growth.

Global laminate flooring market witnessed a decline during 2008 and 2009 primarily because of the worldwide economic recession. The negative impact of the recession was clearly evident across the geographies. While, over capacity resulted from weak demand led to fall in prices and reduced margins, the increase in prices of oil, the basis for production of majority resins in laminates, pressured the manufacturers to a noticeable extent during 2008 and 2009. In addition, other factors such as decline in hardwood prices and emergence of low-priced luxury vinyl tile (LVT) dented the market prospects.

Nevertheless, the expected recovery of new residential construction from low levels seen in the past couple of years is likely to infuse new demand for laminate flooring and other kinds of flooring. However, the new housing is not a large market for laminate flooring as most of laminate flooring business comes from replacement market. Economic recovery is expected to increase the disposable income, thereby enhancing the demand for home renovations, which is likely to create new demand for the floor replacement, and thereby creating opportunities for laminate flooring. The prices of laminate flooring are also expected to level up and match with the growth pattern accompanying inflation and increased costs of raw material.

Major players profiled in the report include Abet Inc., Alloc Inc., Alsafloor SA, Armstrong World Industries Inc., Balterio Laminate Flooring, Beaulieu International Group, Berry Floor, BHK of America Inc., Bruce Flooring, Classen Group, Egger Retail Products GmbH, Faus Group Inc., Formica Corporation, Hamberger Industriewerke GmbH, HUGA Hubert Gaisendrees GmbH & Co. KG, Kaindl Flooring GmbH, Kronospan Holdings Ltd., Kronotex GmbH & Co KG, Mannington Mills Inc., Mohawk Industries Inc., Pergo AB, Pergo LLC, Pfleiderer AG, Robina Flooring Sdn Bhd, Roysol SA, Shaw Industries Inc., Skema Srl, Sonae Industria SGPS S.A, Tarkett USA Inc., Uniboard Canada Inc., Unilin Group, Wilsonart International Inc., and Witex International Flooring GmbH.

The report titled Laminate Flooring: A Global Strategic Business Report provides a comprehensive review of the laminate flooring markets, impact of recession on the markets, current market trends, key growth drivers, competitive scenario, product overview, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for laminate flooring market for the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, the Middle East and Latin America. Key end-use segments analyzed include new housing starts, residential replacement (including DIY inst.), and commercial markets. Also, a six-year (2001-2006) historic analysis is provided for additional perspective.

View Full Report Details: http://www.companiesandmarkets.com/Market-Report/laminate-flooring-a-global-strategic-business-report-400851.asp

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England-- (SBWIRE) -- 11/16/2010 -- The psoriasis drugs market is expected to witness robust growth, as anti-TNF therapies continue to gain momentum. Enbrel and Humira are expected to drive the psoriasis drugs market through 2015. Nevertheless, factors expected to drive success of topical therapies include emergence of new, improved products in continuation of the existing therapies; introduction of new vehicles for topical drug delivery; and accessibility of Calcipotriol ointment. The world market for psoriasis drugs is projected to exceed $7.3 billion by the year 2015.

Psoriasis is one of the most widespread autoimmune diseases and affects more than 2% of the total global population. The disease is characterized by the presence of red, scaly patches known as psoriatic plaques, which are inflamed and are areas of excessive skin production. Psoriasis has no known cause, but is strongly linked to genetics. Psoriasis cannot be cured, but there are several therapies available that can help alleviate symptoms and improve the quality of life of patients.

The United States dominates the world psoriasis drugs market. The US is also the fastest growing regional market for psoriasis therapeutics. Systemic drugs, encompassing conventional systemic drugs and biologics, dominate the global psoriasis drugs market. Of all patients treated with a systemic drug therapy, the number of patients treated with biologics is expected to double in the next six to eight years. Though other treatment options also are available, such as phototherapy, genericized conventional systemic agents and topical agents account for the largest share of volume prescriptions for psoriasis treatment. Taclonex, a vitamin D analog (calcitriol) and anti-inflammatory corticosteroid (betamethasone) combination product, dominates the global market for topical drugs.

The report titled Psoriasis Drugs: A Global Strategic Business Report provides a comprehensive review of psoriasis market, disease prevalence, market trends, market drivers, marketed drugs, systemic drugs, biologics, topical drugs, potential drugs, clinical trials, product introductions/approvals, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including The United States, Japan, Europe, and Rest of World. The study analyzes market data and analytics in terms of value sales for psoriasis drugs by route of drug administration, including Systemic Drugs, and Topical Drugs.

Key players profiled in the report include Abbott Laboratories, Amgen Inc., Almirall SA, Astellas Pharma US Inc., Biogen Idec Inc., Eisai Co. Ltd., Galderma Laboratories, Isis Pharmaceuticals Inc., Johnson & Johnson Company, LEO Pharma A/S, Merck & Co. Inc., Novartis AG, Stiefel Laboratories Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Vertex Pharmaceuticals Inc., and Wyeth.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=5QEQW7D0M289238&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- Greater bandwidth requirements, increase in consumer demand for bundled services, and ambitious plans to upgrade traditional copper networks will trigger global FTTH/B subscriptions to reach 183.9 million by 2015. Fiber is the enabler of greater bandwidth, residential high-speed video and data, and high bandwidth business services, such as IP VPNs, video, and business Ethernet at significantly lower capital and operating expenses.

Requirements for advanced bandwidth to support HDTV, IPTV, multi-stream video services, high maintenance cost of copper infrastructure, enhanced FTTH interoperability, cost savings and innovations in the optical infrastructure and convergence of multiple services on to a single network are some of the prime reasons for growth of FTTH networks. Given an intensified battleground, the economic success of both existing as well as new service providers will largely depend on the ability to deliver a wide range of offerings including bundled voice, data and video services for subscribers. In an attempt to deploy attractive service packages and capture large volume of subscribers, service providers have invested heavily to replace the traditional last mile networks with an end-to-end fiber access network, in addition to investments in FTTH/B. Also, the liberalization of regulatory regimes in several foreign countries and support from governments for transition to FTTH/B bodes well for the market.

Although FTTH/B is a capital intensive and long-term strategic investment, economic slowdown will have minimal effect on deployment projects, as operators are expected to continue with scheduled network deployments. Seemingly paradoxical, the most spontaneous need to curtail costs in an unfavorable business environment is overridden with a simultaneous need to develop a platform for future growth. Additionally, the recession induced lower infrastructure costs makes an economic case for carriers and network operators to persevere with their project schedules.

As stated by the new market research report on Fiber to the Home/Building (FTTH/B), Asia-Pacific including Japan collectively accounts for about 82% share of the global FTTH/B market estimated in 2009. Asia will continue to be the favorable market for FTTH/B deployments during the next five years. While the boom in the Asia Pacific FTTx market over the last few years was primarily driven by mass-scale deployments in South Korea and Japan, the dynamism is now clearly pointing towards China. The number of FTTH/B subscribers in China will continue to explode with rising number of network deployments. Service providers are increasingly turning to FTTH as the next-gen residential broadband access technology, predominantly in areas where DSL penetration has reached its maturity and vendors are seeking to increase their ARPUs.

The report titled Fiber to the Home Building (FTTH/B): A Global Strategic Business Report provides a comprehensive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The report analyzes the subscriber base for FTTH/B in major geographic markets including North America, Japan, Europe, Asia-Pacific, and Rest of World. The study further analyzes the Asian FTTH/B market by the following segments - Fiber-to-the-home (FTTH) and Fiber-to-the-building (FTTB).

Key players dominating the marketplace include Alcatel-Lucent, Alliance Fiber Optic Products Inc, Alloptic Inc, Aurora Networks Inc, Calix Network Inc, ColorChip Limited, EMCORE Corporation, Enablence Technologies Inc, Fujikura Ltd, Sigma-Links Inc, Harmonic Inc, Hitachi Limited, Salira Systems Inc, Ikanos Communications Inc, Motorola Broadband Communications, NeoPhotonics Corporation, PacketFront Systems AB, PMC-Sierra Inc, Source Photonics Inc, Sumitomo Electric Industries Ltd, Sumitomo Electric Device Innovations U.S.A. Inc, Teknovus Inc, Telefonaktiebolaget LM Ericsson, Tellabs Inc, and ZTE Corporation, among others.

View more details on the report: http://www.companiesandmarkets.com/r.ashx?id=LACJHYFS6289261&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, England -- (SBWIRE) -- 11/16/2010 -- The United States represents a major market in the world ready-mix concrete market. However, the growth in the mature western countries clearly lags behind the projected market growth in emerging countries. Ready mix concrete markets in Asia and Latin America are driven by the growth in infrastructure and commercial sectors. In the African and the Middle East markets, significant increase in the self-construction and residential sectors positively impacted the momentum in the ready mix concrete market.

The world market for Ready-Mix Concrete is projected to reach $105.2 billion by the year 2015. This is primarily driven by rapid growth in infrastructure, residential sectors, and non-residential sectors in various parts of the world. Further, the rapidly growing demand for the ready-mix concrete in urban areas will also contribute to the market growth.

Ready-mix concrete industry plays a vital role in construction sector. The market is more prominent in developed regions including the US, and most of the Western European regions such as France, Germany, Italy, the UK, and Spain. Conversely, in the case of developing markets such as China, India, Brazil, South Africa, and others, this is a small, but growing market. The main factor responsible for the ready-mix concrete market's growth is high demand for such concrete, especially in urban areas. Ready-mix concrete is mainly useful for buildings that are located in congested locations that provide little space for storing aggregates and mixer siting. Ready-mix concrete is useful when small amounts of concrete is needed or in case concrete is to be placed periodically. Some factors affecting the ready-mix concrete industry include environmental concerns, maintaining professional standards, and regional laws related to heavy transportation.

Ready mix concrete industry is a highly competitive industry. The competitors range from small-scale, owner-operated private suppliers to operating units/subsidiaries of large, vertically integrated cement and aggregates manufacturers. Usually, vertically integrated manufacturers possess greater manufacturing, marketing, and financial resources than others in the industry and enjoy competitive advantage over others.

The report titled Ready-Mix Concrete: A Global Strategic Business Report provides a comprehensive review of market trends, product overview, competition, product introductions/innovations, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including the US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America.

Key players profiled in the report include Aggregate Industries Holdings Ltd., Buzzi Unicem S.p.A., Dyckerhoff AG, CEMEX, S.A. de C.V., CEMEX UK Operations Ltd., CRH plc, Hanson Cement Ltd., HeidelbergCement AG, Holcim Ltd., Italcementi Group, Lafarge Aggregates & Concrete, Tarmac Limited, Texas Industries Inc., U.S. Concrete Inc., Vicat SA, and Vulcan Material Company.

View Full Report Details: http://www.companiesandmarkets.com/r.ashx?id=J762383KO289236&prk=c34cdcdbcee15ae68d55d5fb6c49c818

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm